Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Graha Mitra Asia Tbk. (RELF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Graha Mitra Asia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Graha Mitra Asia Tbk. trades at Rp35 (market cap 194.75B, 2.1M 24h volume). The key difference: Graha Mitra Asia Tbk. is the larger of the two by market cap, and Graha Mitra Asia Tbk. is more actively traded (2.1M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | RELF | |
|---|---|---|
Market Cap | 164.65B | 194.75B |
Volume | 62.5K | 2.1M |
Lot | 625 | 20.97K |
Turnover | 15.03M | 71.16M |
Average Price | 240.55 | 33.93 |
Value | 15.03M | 71.16M |
Indicative Equilibrium Price | 238 | 35 |
Indicative Equilibrium Volume | 100 | 90 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Graha Mitra Asia Tbk.
PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.
Read more on RELF →
